BioCryst Pharmaceuticals | Interessi Passivi Sul Debito

Interest Expense On Debt Cambiamento Data
Alnylam Pharmaceuticals USD 31.34M 445K 2023-12
Gilead Sciences USD 252M 20M 2023-12
Incyte USD 804K 181K 2023-12
Ionis Pharmaceuticals USD 4.56M 355K 2023-12
Neurocrine Biosciences USD 1.1M 200K 2023-09
PTC Therapeutics USD 44.28M 16.11M 2023-12
Regeneron Pharmaceuticals USD 18.3M 500K 2023-12
Roche Holding CHF 401M 53M 2023-06
Sarepta Therapeutics USD 5.23M 5K 2023-09
Vertex Pharmaceuticals USD 10.9M 300K 2023-09



BioCryst Pharmaceuticals Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.